Biotherapeutics

TABLE OF CONTENTS

Volume 84, Issue 5 (November 2008)

Top

In This Issue

Top

Editorial

Editorial

Clinical Pharmacology in the Era of Biotherapeutics

RL Lalonde and P Honig

Clin Pharmacol Ther 84: 533-536; doi:10.1038/clpt.2008.182

Top

News & Views

Highlights

Highlights

Clin Pharmacol Ther 84: 538-539; doi:10.1038/clpt.2008.197

ASCPT News

ASCPT News

Clin Pharmacol Ther 84: 540-541; doi:10.1038/clpt.2008.198

Top

Perspectives

Commentary

Bioinformatic Networks: Molecular Reticles for Pinpointing Pharmacological Target Selection

RS Faustino and A Terzic

Clin Pharmacol Ther 84: 543-545; doi:10.1038/clpt.2008.181

See also: Article by Hwang et al.

Letters to the Editor

Pharmacodynamics of Propofol in Critically Ill Patients

D Takizawa, E Takizawa, H Hiraoka and S Saito

Clin Pharmacol Ther 84: 546; advance online publication, July 23, 2008; doi:10.1038/clpt.2008.145

Response to "Pharmacodynamics of Propofol in Critically Ill Patients"

CAJ Knibbe and MYM Peeters

Clin Pharmacol Ther 84: 547; advance online publication, September 17, 2008; doi:10.1038/clpt.2008.183

Top

State of the Art

State of the Art

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

W Wang, EQ Wang and JP Balthasar

Clin Pharmacol Ther 84: 548-558; advance online publication, September 10, 2008; doi:10.1038/clpt.2008.170

Top

Research

Report

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

IS Song, HJ Shin, EJ Shim, IS Jung, WY Kim, JH Shon and JG Shin

Clin Pharmacol Ther 84: 559-562; advance online publication, April 9, 2008; doi:10.1038/clpt.2008.61

Articles

Identification of Information Flow-Modulating Drug Targets: A Novel Bridging Paradigm for Drug Discovery

W-C Hwang, A Zhang and M Ramanathan

Clin Pharmacol Ther 84: 563-572; advance online publication, July 9, 2008; doi:10.1038/clpt.2008.129

See also: Commentary by Faustino & Terzic
Role of Pegylated Interferon-alpha-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

LF Lopez-Cortes, B Valera-Bestard, A Gutierrez-Valencia, R Ruiz-Valderas, L Jimenez, A Arizcorreta, A Terrón and P Viciana

Clin Pharmacol Ther 84: 573-580; advance online publication, July 2, 2008; doi:10.1038/clpt.2008.110

Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding

H Schelleman, WB Bilker, CM Brensinger, X Han, SE Kimmel and S Hennessy

Clin Pharmacol Ther 84: 581-588; advance online publication, August 6, 2008; doi:10.1038/clpt.2008.150

Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4beta-Hydroxycholesterol

KP Kanebratt, U Diczfalusy, T Bäckström, E Sparve, E Bredberg, Y Böttiger, TB Andersson and L Bertilsson

Clin Pharmacol Ther 84: 589-594; advance online publication, July 23, 2008; doi:10.1038/clpt.2008.132

Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine

M Malik, J-O Andreas, K Hnatkova, J Hoeckendorff, W Cawello, M Middle, R Horstmann and M Braun

Clin Pharmacol Ther 84: 595-603; advance online publication, July 23, 2008; doi:10.1038/clpt.2008.143

Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

Clin Pharmacol Ther 84: 604-612; advance online publication, August 13, 2008; doi:10.1038/clpt.2008.156

Availability and Choice of Antimalarials at Medicine Outlets in Ghana: The Question of Access to Effective Medicines for Malaria Control

KO Buabeng, M Duwiejua, LK Matowe, F Smith and H Enlund

Clin Pharmacol Ther 84: 613-619; advance online publication, July 9, 2008; doi:10.1038/clpt.2008.130

Top

Discovery & Development

Translational Medicine

Stem Cells: Biologics for Regeneration

TJ Nelson, A Behfar and A Terzic

Clin Pharmacol Ther 84: 620-623; advance online publication, August 13, 2008; doi:10.1038/clpt.2008.146

Development

Safety Issues Specific to Clinical Development of Protein Therapeutics

CA Haller, ME Cosenza and JT Sullivan

Clin Pharmacol Ther 84: 624-627; advance online publication, August 13, 2008; doi:10.1038/clpt.2008.158

Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides

L Sepp-Lorenzino and MK Ruddy

Clin Pharmacol Ther 84: 628-632; advance online publication, September 17, 2008; doi:10.1038/clpt.2008.174

Top

Regulation & Use

Public Policy

Current Regulatory and Legal Considerations for Follow-On Biologics

RF Kingham and E Lietzan

Clin Pharmacol Ther 84: 633-635; advance online publication, August 20, 2008; doi:10.1038/clpt.2008.159

Top

Erratum

Erratum

ERRATUM: Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis FREE

Clin Pharmacol Ther 84: 636; doi:10.1038/clpt.2008.180

Extra navigation

.

naturejobs

ADVERTISEMENT